- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07679087
Study of the Frequency and Characteristics of Pain Symptoms in Restless Legs Syndrome (PAIN-RLS)
Restless Legs Syndrome (RLS) is a neurological disorder affecting between 4% and 29% of adults. It is characterized by an urge to move the legs or other parts of the body, often accompanied by unpleasant and sometimes painful sensations. The pathophysiology of RLS, whether associated with pain or not, remains poorly understood, and only a limited number of studies have specifically investigated this aspect.
The aim of this study is to determine the prevalence of the painful component of symptoms in a large cohort of patients with RLS, to further characterize its clinical features, and to assess its impact on patients' quality of life. This work could improve the identification of patients experiencing pain, enhance our understanding of pain characteristics in RLS, and help optimize patient management. Furthermore, in the context of emerging therapeutic approaches such as neuromodulation, a better characterization of pain in RLS may contribute to the development and evaluation of new treatment strategies. This is particularly relevant given the high prevalence of RLS and its substantial impact on patients' quality of life.
Participants will be recruited either through their neurologist during routine follow-up visits at the Neurology Department of Clermont-Ferrand University Hospital or through the France Ekbom Association. Individuals interested in participating will be provided with access to the online questionnaire via a QR code or a dedicated web link. One thousand patients will be include in this study (RIPH type 3). The online questionnaire is expected to take approximately 30 minutes to complete. It includes the collection of demographic data (age, sex, lifestyle factors, weight, height, employment status, comorbidities, and dietary habits), as well as questions regarding the patient's medical history and sleep habits.
The questionnaire also includes validated instruments assessing sleep, pain, RLS severity, anxiety and depression, and quality of life.
At the end of the questionnaire, participants will be invited to take part in an optional ancillary study aimed at validating the French translation of the Restless Legs Syndrome Quality of Life questionnaire (RLS-QOL). Participants who agree to participate will complete the questionnaire once at baseline and will subsequently receive an email reminder to complete it a second time two weeks later. This test-retest procedure will be used to assess the reproducibility of the French-adapted version of the questionnaire.
Studieoversigt
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Lise LACLAUTRE
- Telefonnummer: +33473754963
- E-mail: promo_interne_drci@chu-clermontferrand.fr
Studiesteder
-
-
-
Clermont-Ferrand, Frankrig
- CHU de Clermont-Ferrand
-
Ledende efterforsker:
- Livia FANTINI
-
Kontakt:
- Lise Laclautre
- Telefonnummer: 33473754963
- E-mail: promo_interne_drci@chu-clermontferrand.fr
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Male or female participants aged 18 years or older.
- Diagnosis of Restless Legs Syndrome (RLS) according to the criteria of the International Classification of Sleep Disorders, Third Edition (ICSD-3).
- French-speaking.
Exclusion Criteria:
- Patient under guardianship, curatorship, or legal protection measures.
- Patient who has never had an appointment with a neurologist as part of their SJSR care pathway.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
RLS patient
Patients with a diagnosis of Restless Legs Syndrome (RLS) confirmed by a sleep specialist
|
The online questionnaire is expected to take approximately 30 minutes to complete. It includes the collection of demographic data (age, sex, lifestyle factors, weight, height, employment status, comorbidities, and dietary habits), as well as questions regarding the patient's medical history and sleep habits. The questionnaire also includes validated instruments assessing sleep, pain, RLS severity, anxiety and depression, and quality of life. At the end of the questionnaire, participants will be invited to take part in an optional ancillary study aimed at validating the French translation of the Restless Legs Syndrome Quality of Life questionnaire (RLS-QOL). Participants who agree to participate will complete the questionnaire once at baseline and will subsequently receive an email reminder to complete it a second time two weeks later. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Pain evaluation according to the Brief Pain Inventory (PBI)
Tidsramme: at day 0
|
at day 0
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Pain characteristics using the DN4 questionnaire
Tidsramme: at day 0
|
at day 0
|
|
RLS severity using the International Restless Legs Syndrome Rating Scale (IRLS)
Tidsramme: at day 0
|
at day 0
|
|
Fibromyalgia using the FIRST (Fibromyalgia Rapid Screening Tool)
Tidsramme: at day 0
|
at day 0
|
|
Biopsychosocial dimensions of pain according to the Pain Catastrophizing Scale (PCS).
Tidsramme: at day 0
|
at day 0
|
|
Anxiety and depression using the Hospital Anxiety and Depression Scale (HADS)
Tidsramme: at day 0
|
at day 0
|
|
Quality of life using the EQ-5D-5L
Tidsramme: at day 0
|
at day 0
|
|
Daytime sleepiness using Epworth Sleepiness Scale (ESS).
Tidsramme: at day 0
|
at day 0
|
|
RLS-specific quality of life using the Restless Legs Syndrome Quality of Life questionnaire (RLS-QOL).
Tidsramme: at day 0
|
at day 0
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Livia FANTINI, University Hospital, Clermont-Ferrand
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RNI 2026 FANTINI (PAIN-RLS)
- 2026-A00401-50 (Anden identifikator: IDRCB)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med RLS
-
XenoPort, Inc.Rekruttering
-
China Medical University, TaiwanChanghua Christian HospitalAfsluttet
-
Mundipharma Research GmbH & Co KGAfsluttetModerat til svær idiopatisk RLS med dagtidssymptomerSpanien, Sverige, Tyskland
-
Noctrix Health, Inc.RekrutteringRestless Legs Syndrome (RLS)Forenede Stater
-
University of Alabama at BirminghamRekrutteringRestless Leg Syndrome (RLS) | Rygmarvsstimulering (SCS)Forenede Stater
-
XenoPort, Inc.Rekruttering
-
Clinica ARS MedicaIkke rekrutterer endnuRestless Leg Syndrome (RLS)Schweiz
-
Wenxia JiangIkke rekrutterer endnuRestless Legs Syndrome (RLS)
-
Pamukkale UniversityAfsluttetRestless Legs Syndrome (RLS)Tyrkiet (Türkiye)
-
Cairo UniversityAfsluttetHæmodialyse | Restless Leg Syndrome (RLS)Egypten
Kliniske forsøg med Patients with RLS
-
ReAlta Life Sciences, Inc.Trukket tilbageCOVID-19 | Akut lungeskade | ALIForenede Stater
-
ReAlta Life Sciences, Inc.Aktiv, ikke rekrutterendeAkut forværring af kronisk obstruktiv lungesygdomForenede Stater
-
ReAlta Life Sciences, Inc.CTI Clinical Trial and Consulting ServicesRekrutteringSteroid Refractory GVHDTyskland, Spanien, Forenede Stater
-
Rubedo Life Sciences, Inc.Rekruttering
-
Stanford UniversityRekrutteringRestless Legs SyndromeForenede Stater
-
ReAlta Life Sciences, Inc.Premier ResearchRekruttering
-
ReAlta Life Sciences, Inc.Afsluttet
-
UNC Lineberger Comprehensive Cancer CenterAfsluttetBrystkræft | Fysisk aktivitet | AldringForenede Stater
-
Hasselt UniversityAfsluttetMultipel scleroseBelgien